Vijay Krishna

Vijay Krishna, M. Kuppili, currently serves as Associate Director - MSAT (Bioconjugations) and previously held a managerial position in MSAT (mRNA) at Lonza. Prior experience includes roles as Principal Protein Scientist at Piramal Pharma Solutions, Study Director (Viral Clearance) at Merck Group, Sr. Development Scientist at Quotient Limited, and Process Development Scientist at AB Biotechnology.